Gavin Clark-Gartner
Stock Analyst at Evercore ISI
Total Price Targets
14
Stocks Covered
10
Sectors
Healthcare
Most Recent
Mar 4, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Gavin Clark-Gartner
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| MIRM | Mirum Pharmaceuticals, Inc. | $126.00 | $97.47 | +29.3% | 2 | Mar 4, 2026 |
| RARE | Ultragenyx Pharmaceutical Inc. | $34.00 | $24.79 | +37.2% | 1 | Feb 18, 2026 |
| ABBV | AbbVie Inc. | $228.00 | $206.29 | +10.5% | 1 | Feb 4, 2026 |
| VRDN | Viridian Therapeutics, Inc. | $45.00 | $13.41 | +235.6% | 2 | Jan 28, 2026 |
| DYN | Dyne Therapeutics, Inc. | $36.00 | $17.50 | +105.7% | 2 | Dec 15, 2025 |
| VERA | Vera Therapeutics, Inc. | $97.00 | $35.31 | +174.7% | 1 | Dec 8, 2025 |
| INSM | Insmed Incorporated | $180.00 | $133.75 | +34.6% | 1 | Oct 1, 2025 |
| FHTX | Foghorn Therapeutics Inc. | $20.00 | $4.79 | +317.5% | 1 | Aug 19, 2024 |
| KRYS | Krystal Biotech, Inc. | $206.00 | $265.25 | -22.3% | 1 | Aug 12, 2024 |
| SRPT | Sarepta Therapeutics, Inc. | $179.00 | $21.60 | +728.7% | 2 | Aug 8, 2024 |
Recent Activity
- Mar 4, 2026— Set$126.00price target onMIRM(Mirum Pharmaceuticals, Inc.)
- Feb 18, 2026— Set$34.00price target onRARE(Ultragenyx Pharmaceutical Inc.)
- Feb 4, 2026— Set$228.00price target onABBV(AbbVie Inc.)
- Jan 28, 2026— Set$45.00price target onVRDN(Viridian Therapeutics, Inc.)
- Jan 20, 2026— Set$44.00price target onVRDN(Viridian Therapeutics, Inc.)
- Dec 15, 2025— Set$36.00price target onDYN(Dyne Therapeutics, Inc.)
- Dec 8, 2025— Set$97.00price target onVERA(Vera Therapeutics, Inc.)
- Nov 6, 2025— Set$38.00price target onDYN(Dyne Therapeutics, Inc.)
- Oct 1, 2025— Set$180.00price target onINSM(Insmed Incorporated)
- Aug 19, 2024— Set$20.00price target onFHTX(Foghorn Therapeutics Inc.)
- Aug 12, 2024— Set$206.00price target onKRYS(Krystal Biotech, Inc.)
- Aug 8, 2024— Set$179.00price target onSRPT(Sarepta Therapeutics, Inc.)
- Jun 24, 2024— Set$185.00price target onSRPT(Sarepta Therapeutics, Inc.)
- Jun 17, 2024— Set$62.00price target onMIRM(Mirum Pharmaceuticals, Inc.)
Frequently Asked Questions
Who is Gavin Clark-Gartner?
Gavin Clark-Gartner is a stock analyst at Evercore ISI covering 10 stocks primarily in Healthcare. They have issued 14 price targets since Jun 17, 2024.
What stocks does Gavin Clark-Gartner cover?
Gavin Clark-Gartner currently covers 10 stocks, including MIRM, VRDN, DYN, SRPT, RARE.
What is Gavin Clark-Gartner's latest price target?
Gavin Clark-Gartner's most recent price target was $126.00 on MIRM (Mirum Pharmaceuticals, Inc.), set on Mar 4, 2026.
What is Gavin Clark-Gartner's highest price target?
Gavin Clark-Gartner's highest issued price target is $228.00 on ABBV, set on Feb 4, 2026.
More Analysts at Evercore ISI
Coverage based on publicly published price targets. Not investment advice.